Yildiz R - Search Results

1

F-18 FDG uptake due to acinetobacter infection causing misinterpretation of treatment response in a lymphoma patient.

Yildiz R, Coskun U, Kapucu O, Kaya AO, Akdemir UO, Benekli M, Buyukberber S. Yildiz R, et al. Clin Nucl Med. 2007 Jun;32(6):471-3. doi: 10.1097/RLU.0b013e318053ed08. Clin Nucl Med. 2007. PMID: 17515759 No abstract available.

2

Disseminated extranodal NK/T-cell lymphoma, nasal type, with multiple subcutaneous nodules: utility of 18F-FDG PET in staging.

Berk V, Yildiz R, Akdemir UO, Akyurek N, Karabacak NI, Coskun U, Benekli M. Berk V, et al. Among authors: yildiz r. Clin Nucl Med. 2008 May;33(5):365-6. doi: 10.1097/RLU.0b013e31816a7a23. Clin Nucl Med. 2008. PMID: 18431160

3

Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.

Coskun U, Buyukberber S, Yaman E, Uner A, Er O, Ozkan M, Dikilitas M, Oguz M, Yildiz R, B DY, Kaya AO, Benekli M. Coskun U, et al. Among authors: yildiz r. Neoplasma. 2008;55(1):65-70. Neoplasma. 2008. PMID: 18190244

4

Efficacy and toxicity of preoperative chemotherapy with docetaxel and epirubicin in locally advanced invasive breast cancer.

Kaya AO, Coskun U, Buyukberber S, Benekli M, Tekin E, Cifter C, Ozturk B, Yildiz R, Yaman E, Uner A, Yamac D. Kaya AO, et al. Among authors: yildiz r. J BUON. 2010 Apr-Jun;15(2):248-54. J BUON. 2010. PMID: 20658717

5

Capecitabine plus oxaliplatin (xelox) in the treatment of chemotherapy-naive patients with metastatic colorectal cancer.

Yaman E, Uner A, Er O, Coskun U, Buyukberber S, Dikilitas M, Polat M, Yamac D, Kaya AO, Yildiz R, Ozturk B, Benekli M. Yaman E, et al. Among authors: yildiz r. Med Oncol. 2007;24(4):431-5. doi: 10.1007/s12032-007-0035-7. Med Oncol. 2007. PMID: 17917094 Clinical Trial.

6

Solitary iris metastasis from breast cancer with dramatic course: case report.

Ozturk B, Buyukberber S, Coskun U, Yaman E, Yildiz R, Kaya AO, Oner Y, Benekli M. Ozturk B, et al. Among authors: yildiz r. Med Oncol. 2007;24(4):463-5. doi: 10.1007/s12032-007-0019-7. Med Oncol. 2007. PMID: 17917101

7

The results of three different treatment modalities in patients with locally advanced nasopharyngeal carcinoma.

Ozturk B, Buyukberber S, Akmansu M, Coskun U, Yamac D, Uner A, Yaman E, Yildiz R, Kaya AO, Bora H, Unsal D, Pak Y, Benekli M. Ozturk B, et al. Among authors: yildiz r. Med Oncol. 2008;25(3):269-73. doi: 10.1007/s12032-007-9029-8. Epub 2007 Dec 15. Med Oncol. 2008. PMID: 18080790

8

Synchronize primary breast osteosarcoma and contralateral benign cystosarcoma phylloides: radiologic and pathologic imaging.

Uner A, Ozturk B, Benekli M, Coskun U, Kocak S, Kaya AO, Unsal D, Erekul S, Yaman E, Yildiz R, Buyukberber S. Uner A, et al. Among authors: yildiz r. Breast J. 2008 Jan-Feb;14(1):109-10. doi: 10.1111/j.1524-4741.2007.00533.x. Breast J. 2008. PMID: 18186876 No abstract available.

9

Gemcitabine plus capecitabine combination in metastatic breast cancer patients previously treated with anthracyclines and taxanes.

Benekli M, Yildiz R, Uner A, Er O, Yamac D, Alkis N, Coskun U, Camci C, Buyukberber S. Benekli M, et al. Among authors: yildiz r. Oncology. 2007;72(5-6):308-13. doi: 10.1159/000113053. Epub 2008 Jan 14. Oncology. 2007. PMID: 18198492

10

Single agent gemcitabine in the second-line treatment of advanced non-small cell lung cancer after treatment with taxane + platinum regimens.

Coskun U, Kaya AO, Buyukberber S, Benekli M, Uner A, Dikilitas M, Ozturk B, Yildiz R, Ozkan S, Yaman E, Yamac D. Coskun U, et al. Among authors: yildiz r. Med Oncol. 2008;25(2):133-6. doi: 10.1007/s12032-007-9005-3. Epub 2007 Sep 14. Med Oncol. 2008. PMID: 18488154

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters